Lenox Equity Partners, LP (“LEP”) focuses on supporting management teams in acquiring privately-held, lower middle market companies as well as corporate orphans.
LEP makes equity and mezzanine investments in companies in the manufacturing, distribution, healthcare and business services industries with revenues of $10 million to $25 million.
Lenox Equity Partners’ Limited Partners are current and former senior executives of Fortune 1000 companies. Our LPs are members of our Investment Committee (on a rotating basis), take Board seats on portfolio companies and assist the Fund in mentoring our management teams.
Recent News
Lenox Equity Partners, LP completes subordinated debt investment in American BioCareJanuary 2012 – Atlanta, Georgia – Lenox Equity Partners, LP (“LEP”) has made a subordinated debt investment in American BioCare. LEP provided capital to support the acquisition of home healthcare agencies in Michigan and Texas. American BioCare is a platform entity focused on distinctive health care services providers converging on the treatment of chronic, debilitating conditions in the home. The company’s goal is to provide world-class medical, skilled, therapy and personal care services in the most comfortable and cost-effective settings to a broad customer base in the United States.